Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
R&D Systems™ Human CCL3L1/MIP-1 alpha Isoform LD78 beta Recombinant Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
Manufacturer: R&D Systems™ 509MI025/CF
This item is not returnable.
View return policy
Description
The Recombinant Human CCL3L1/MIP-1 alpha Isoform LD78 beta is derived from E. coli. The Recombinant Human CCL3L1/MIP-1 alpha Isoform LD78 beta has been validated for the following applications: Bioactivity.Specifications
| Lyophilized from a 0.2μm filtered solution in Acetonitrile and TFA. | |
| 7.8 kDa | |
| 97%, by SDS-PAGE under reducing conditions and visualized by silver stain. | |
| E. coli-derived human CCL3L1/MIP-1 alpha Isoform LD78 beta protein Ala24-Ala93 | |
| Unconjugated |
| 6349 | |
| CCL3L1/MIP-1 alpha Isoform LD78 beta | |
| 25μg | |
| Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution. | |
| Yes |
Provide Content Correction
We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.
Product Title